Cargando…
Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies
BACKGROUND: Current vaccines against HPVs are constituted of L1 protein self-assembled into virus-like particles (VLPs) and they have been shown to protect against natural HPV16 and HPV18 infections and associated lesions. In addition, limited cross-protection has been observed against closely relat...
Autores principales: | Combelas, Nicolas, Saussereau, Emilie, Fleury, Maxime JJ, Ribeiro, Tatiana, Gaitan, Julien, Duarte-Forero, Diego F, Coursaget, Pierre, Touzé, Antoine |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852459/ https://www.ncbi.nlm.nih.gov/pubmed/20334659 http://dx.doi.org/10.1186/1479-5876-8-28 |
Ejemplares similares
-
Identification of the Neutralizing Epitopes of Merkel Cell Polyomavirus Major Capsid Protein within the BC and EF Surface Loops
por: Fleury, Maxime J. J., et al.
Publicado: (2015) -
Production of Human papillomavirus pseudovirions in plants and their use in pseudovirion-based neutralisation assays in mammalian cells
por: Lamprecht, Renate L, et al.
Publicado: (2016) -
Identification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31
por: Fleury, M. J. J., et al.
Publicado: (2006) -
High-Throughput Pseudovirion-Based Neutralization Assay for Analysis of Natural and Vaccine-Induced Antibodies against Human Papillomaviruses
por: Sehr, Peter, et al.
Publicado: (2013) -
Novel Production of Bovine Papillomavirus Pseudovirions in Tobacco Plants
por: Pietersen, Inge, et al.
Publicado: (2020)